(19)
(11) EP 1 957 110 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
23.12.2020 Bulletin 2020/52

(45) Mention of the grant of the patent:
23.09.2020 Bulletin 2020/39

(21) Application number: 06844860.4

(22) Date of filing: 05.12.2006
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 9/20(2006.01)
A61K 47/10(2017.01)
A61K 47/36(2006.01)
A61K 47/46(2006.01)
 A61K 9/16(2006.01)
A61K 9/50(2006.01)
A61K 47/26(2006.01)
A61K 47/44(2017.01)
A61K 47/06(2006.01)
(86) International application number:
PCT/US2006/046470
(87) International publication number:
WO 2007/067582 (14.06.2007 Gazette 2007/24)

(54)

PROCESS FOR MANUFACTURING CHEWABLE DOSAGE FORMS FOR DRUG DELIVERY AND PRODUCTS THEREOF

VERFAHREN ZUR HERSTELLUNG VON KAUBAREN DOSISFORMEN ZUR ARZNEIVERSORGUNG UND PRODUKTE DARAUS

PROCEDE POUR LA FABRICATION DE FORMES PHARMACEUTIQUES A MACHER POUR L'ADMINISTRATION DE MEDICAMENT ET PRODUITS ASSOCIES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 07.12.2005 US 296181

(43) Date of publication of application:
20.08.2008 Bulletin 2008/34

(73) Proprietor: Bayer HealthCare, LLC
Shawnee, KS 66216 (US)

(72) Inventors:
  • PAULSEN, Neil, E.
    Johns Island, SC 27455 (US)
  • JOHNSON, Roland
    Lexington, NC 27292 (US)
  • COFFEE, Michael
    Greensboro, NC 27455 (US)

(74) Representative: Viering, Jentschura & Partner mbB Patent- und Rechtsanwälte 
Hamborner Straße 53
40472 Düsseldorf
40472 Düsseldorf (DE)


(56) References cited: : 
WO-A1-96/18387
WO-A1-2005/013714
US-A- 5 380 535
US-A1- 2004 234 579
US-B2- 6 613 346
US-B2- 6 868 136
 WO-A1-2004/016252
US-A- 4 710 390
US-A- 5 735 603
US-B1- 6 344 222
US-B2- 6 672 252
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).